Reduce Appetite & Cravings
Take control of cravings. Supports appetite regulation so you feel satisfied sooner and stay on track.
- Online Care
- Fast Prescriptions
- Delivered to Your Door
Semaglutide Injection
Semaglutide is a once-weekly treatment designed to support weight loss by helping control appetite, reduce food intake, and improve metabolic function.
Starting at
$149 /per month
Price includes everything you need; consultation, care, medication, supplies, shipping and support.
No Insurance Required
Free Shipping
Free Medical Visits
GET STARTED
Your Path to Care
01
Complete Your Intake
Answer a few questions online about your health, goals, and medical history.
02
Provider Review
A licensed clinician reviews your information. A phone or video consultation may be required depending on your location and treatment.
03
Delivered to You
If prescribed, your medication ships discreetly to you.
FAQ
Frequently Asked Questions About Semaglutide
Need answers now?
Call 855-768-9959 or email help@ondarx.com
Keeping Your Data Safe
Your medical information is stored on OndaRx's HIPAA-compliant, SOC-2 certified encrypted data enclave.
The OndaRx Difference
What are You Working Toward?
SemaglutideTirzepatide
Lose Weight. Keep Moving Forward.
Semaglutide and Tirzepatide injections with personalized treatment and ongoing medical support.
NAD+SermorelinGlutathione
Age Better. Perform Better.
NAD+, Sermorelin, and Glutathione treatments designed to support energy, recovery, cellular health, and healthy aging.
SildenafilTadalafilFemale Libido Support
Better Sex. Better Connection.
ED treatments for men. Libido support for women. Because sexual wellness is part of whole-body health.
TRTBHRTEnclomiphene
Get Back to Feeling Like You.
TRT and Enclomiphene for men. BHRT for women. Personalized treatment built around your labs, goals, and life.
Hair Growth for MenHair Growth for Women
Fuller Hair Starts Here.
Prescription hair-growth treatments for men and women designed to reduce thinning and support healthier, fuller-looking hair.
